
Company Info
Year Established2023
Contacts
Karin Eisinger, Ph.D.Co-Founder & CEO
Company Description
SyzOnc is developing tumor microenvironment modulators for cancer patients using a tech-enabled, systems-level approach.

SyzOnc is developing tumor microenvironment modulators for cancer patients using a tech-enabled, systems-level approach.